CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 225 enrolled
Drug / intervention
Zonisamidedrug
Likely dose
Zonisamide 400 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00275834
NCT00275834N/ACompleted
CompareCT.gov

Zonisamide for Weight Reduction in Obese Adults

Duke University·interventional·Posted Jan 12, 2006·Updated Jan 12, 2017

In Brief

A clinical study evaluating Zonisamide for Obesity. Completed, enrolled 225 participants across 1 site.

Detailed Summary

The primary aim of this study is to assess long-term weight loss efficacy of zonisamide relative to placebo in obese patients prescribed a dietary intervention.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 12, 2006
Enrollment StartJan 1, 2006
Primary CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 20.5 years ago

Interventions

Zonisamidedrug

zonisamide 400 mg, 200 mg, or placebo